Search results

• Dexamethasone
  ...ressant]]. It is 20 to 30 times more potent than the naturally occurring [[hormone]] [[hydrocortisone]] and 4 to 5 times more potent than [[prednisone]]. ...n augment the [[antiemetic]] effect of [[5-HT3 antagonist|5-HT₃ receptor antagonists]] like [[ondansetron]]. In [[brain tumour]]s (primary or metas
  18 KB (2,498 words) - 16:41, 27 September 2010
• Carbamazepine
  ....<ref>Granger, P. et al. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol. Pharmacol. 47, Carbamazepine may cause [[Syndrome of inappropriate antidiuretic hormone]] (SIADH), since it both increases the release and potentiates the action o
  16 KB (2,164 words) - 16:42, 27 September 2010
• Metformin
  ...dojournals.org/cgi/content/full/91/1/225}}</ref> and, in men, [[lutenizing hormone]] and [[testosterone]].<ref>{{vcite journal |author=Shegem NS, Nasir AM, Jb ...gh AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP |journal=Diabetes |volume=57 |issue=2 |pages=306–14 |year=2008 |pmid=
  66 KB (8,976 words) - 16:47, 27 September 2010
• Aspirin
  ...the experiments in rats, via the action on [[arachidonic acid]] and [[NMDA receptor]]s cascade.<ref name="Gutton">{{Cite journal|author=Guitton MJ, Caston J, R Prostaglandins are local [[hormone]]s produced in the body and have diverse effects in the body, including the
  78 KB (10,918 words) - 16:52, 27 September 2010
• Suramin
  ...ife impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukem ...enegger M |title=Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676 |journal=Br. J. Pharmacol. |volume=146 |issue
  7 KB (906 words) - 16:47, 27 September 2010
• Dopamine
  ...[[neurohormone]] released by the [[hypothalamus]]. Its main function as a hormone is to inhibit the release of [[prolactin]] from the anterior lobe of the [[ Via the [[dopamine receptor]]s, D_1-5, dopamine reduces the influence of the indirect pathway
  48 KB (6,470 words) - 16:48, 27 September 2010
• Spironolactone
  ...). Spironolactone has anti-androgen activity by binding to the [[androgen receptor]] and preventing it from interacting with [[dihydrotestosterone]].<ref>{{ci ...| pmid=16840442 | pmc=1539051 }}</ref> Because it also affects [[androgen receptor]]s and other steroid receptors, it can cause [[gynecomastia]], menstrual ir
  12 KB (1,555 words) - 16:49, 27 September 2010
• Metoclopramide
  ...or|5-HT₃ receptor]] antagonist/[[5-HT receptor|5-HT₄ receptor]] agonist. ...activity, D₂ receptor antagonist activity and 5-HT₄ receptor agonist activity.<ref name="Martindale34">Sweetman S, editor. Martindale: T
  11 KB (1,453 words) - 16:49, 27 September 2010
• Cortisol
  ...''', also known as '''hydrocortisone''', is a [[corticosteroid|steroid]] [[hormone]] or [[glucocorticoid]] produced by the [[adrenal gland]].<ref name="themed ...by the hypothalamus triggers pituitary secretion of adrenal corticotrophic hormone ([[ACTH]]); ACTH is carried by the blood to the adrenal cortex where it tri
  41 KB (5,644 words) - 16:50, 27 September 2010
• Epinephrine
  '''Epinephrine''' (also known as '''adrenaline''') is a [[hormone]] and [[neurotransmitter]].<ref>{{cite pmid|6278965}}</ref>. It increases h ...F02281628}}</ref> In 1901, Takamine successfully isolated and purified the hormone from the adrenal glands of sheep and oxen.<ref>{{cite book |author=Takamine
  22 KB (2,916 words) - 16:50, 27 September 2010
• Template:Antidepressants
  | group2 = [[Receptor antagonist|Receptor antagonist]]s and/or [[Reuptake inhibitor|reuptake inhibitor]]s ...ne]]s and other [[5-HT1A receptor|5-HT_1A receptor]] [[Serotonin receptor agonist|agonist]]s
  13 KB (1,038 words) - 16:53, 27 September 2010
• Template:Pituitary and hypothalamic hormones and analogues
  | title = [[Hypothalamic-pituitary hormone]]s and analogues ([[ATC code H01|H01]]) | group1 = [[Gonadotropin-releasing hormone|GNRH]]
  2 KB (149 words) - 12:10, 19 September 2010
• Template:Major drug groups
  ...}} ''[[renin-angiotensin system]]'' ([[ACE inhibitor]]s, [[Angiotensin II receptor antagonist]]s, [[Renin inhibitor]]s) ...}} [[Fertility medication|Fertility agents]]{{•}} [[Selective estrogen receptor modulator|SERM]]s{{•}} [[Sex steroid|Sex hormones]]
  5 KB (556 words) - 19:23, 27 September 2011
• Template:Peptide hormone agonists and antagonists
  | name = Peptide hormone agonists and antagonists | title = [[Peptide hormone]] receptor agonists and antagonists
  2 KB (199 words) - 12:11, 19 September 2010
• Template:Anxiolytics
  | group3 = [[5-HT1A receptor|5-HT_1A]] [[Serotonin_receptor_agonist|Agonist]]s | group5 = [[Corticotropin releasing hormone antagonist|CRH₁ Antagonist]]s
  4 KB (311 words) - 21:04, 24 September 2010
• Template:Neuropeptidergics
  | group1 = [[Cholecystokinin A receptor|CCK_A]] | group2 = [[Cholecystokinin A receptor|CCK_B]]
  9 KB (713 words) - 12:11, 19 September 2010
• Mydriasis
  Natural release of the hormone [[oxytocin]] can cause mild to moderate mydriasis. Strong sexual arousal ca ...oscyamine]], and [[scopolamine]] antagonize the [[muscarinic acetylcholine receptor|muscarinic acetylcholine]] receptors in the eye. By blocking these receptor
  9 KB (1,223 words) - 09:40, 20 September 2010
• Graves' ophthalmopathy
  ...nt with neither [[anti-microsomal]], anti-[[thyroglobulin]] nor anti-[[TSH receptor]], the [[antibodies]] identified in [[Graves' disease]]. ...r [[antibodies]] (anti-thyroglobulin, anti-microsomal and anti-thyrotropin receptor) and abnormalities in [[thyroid hormones]] level (T3, T4 and TSH) help in s
  15 KB (1,986 words) - 09:40, 20 September 2010
• Polystyrene
  ...ncrease Thyroid Hormone Levels via Down-Regulation of the Aryl Hydrocarbon Receptor (AhR) Target Gene UDP-Glucuronosyltransferase|journal=Environmental Health
  36 KB (5,017 words) - 10:14, 20 September 2010
• List of cutaneous conditions
  ...eriodic syndrome]] (Familial Hibernian fever, TRAPS, Tumor necrosis factor receptor associated periodic syndrome) *[[Leukotriene receptor antagonist-associated Churg–Strauss syndrome]]
  177 KB (19,269 words) - 21:05, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)